Fetal Medicine
Understanding how prenatal risk for aneuploidies (especially Trisomy 21) is calculated is crucial for proper interpretation and counseling. This article walks through the stepwise risk estimation process, starting from maternal age, incorporating first-trimester combined screening, ultrasound soft markers, and finally, non-invasive prenatal testing (NIPT). It’s backed with formulas and real clinical examples. A Priori Risk... Read More
Introduction Non‑Invasive Prenatal Testing (NIPT) has revolutionized prenatal screening by enabling the detection of common aneuploidies through a simple maternal blood sample. But behind every “high risk” or “low risk” result lies complex statistical modeling: most notably involving tools like Z‑scores and Log‑Likelihood Ratios (LLRs). While both aim to assess whether a fetus may have... Read More
15 49.0138 8.38624 arrow 0 bullet 0 4000 1 0 horizontal https://genecommons.com 300 0 1